{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:54:26Z","timestamp":1783950866046,"version":"3.55.0"},"reference-count":222,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072531"],"award-info":[{"award-number":["82072531"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.intimp.2025.115199","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T19:32:54Z","timestamp":1752607974000},"page":"115199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Unraveling APOE4: The dual role in CNS and peripheral inflammation in Alzheimer's disease"],"prefix":"10.1016","volume":"163","author":[{"given":"Xiaohan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zekun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihao","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.intimp.2025.115199_bb0005","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4103\/bc.bc_33_22","article-title":"Gender differences in diagnostic tools, medication, time to medication, and nonmotor symptoms in parkinsonian patients","volume":"8","author":"Skogar","year":"2022","journal-title":"Brain Circ."},{"issue":"2","key":"10.1016\/j.intimp.2025.115199_bb0010","article-title":"Abnormalities of mitochondrial dynamics in neurodegenerative diseases","volume":"6","author":"Gao","year":"2017","journal-title":"Antioxidants (Basel)."},{"issue":"2","key":"10.1016\/j.intimp.2025.115199_bb0015","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1055\/s-0039-1681041","article-title":"Alzheimer's disease including focal presentations","volume":"39","author":"Villain","year":"2019","journal-title":"Semin. Neurol."},{"issue":"4","key":"10.1016\/j.intimp.2025.115199_bb0020","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3233\/JAD-141134","article-title":"Epidemiological and economic burden of Alzheimer\u2019s disease: a systematic literature review of data across Europe and the United States of America","volume":"43","author":"Takizawa","year":"2015","journal-title":"Journal of Alzheimer\u2019s disease\u202f: JAD."},{"issue":"2","key":"10.1016\/j.intimp.2025.115199_bb0025","doi-asserted-by":"crossref","first-page":"73","DOI":"10.31083\/j.jin2102073","article-title":"Infectious agents and Alzheimer's disease","volume":"21","author":"Piekut","year":"2022","journal-title":"J. Integr. Neurosci."},{"issue":"3","key":"10.1016\/j.intimp.2025.115199_bb0030","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4103\/bc.bc_10_23","article-title":"Lecanemab: A hope in the management of Alzheimer's disease","volume":"9","author":"Thakkar","year":"2023","journal-title":"Brain Circ."},{"issue":"6","key":"10.1016\/j.intimp.2025.115199_bb0035","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1007\/s00415-019-09286-0","article-title":"Association between sleep disturbance in Alzheimer's disease patients and burden on and health status of their caregivers","volume":"266","author":"Okuda","year":"2019","journal-title":"J. Neurol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115199_bb0040","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jalz.2011.05.2410","article-title":"Neuropsychiatric symptoms in Alzheimer\u2019s disease","volume":"7","author":"Lyketsos","year":"2011","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.intimp.2025.115199_bb0045","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3233\/JAD-2009-1016","article-title":"Does cognitive impairment influence burden in caregivers of patients with Alzheimer\u2019s disease?","volume":"17","author":"Germain","year":"2009","journal-title":"Journal of Alzheimer\u2019s disease\u202f: JAD."},{"issue":"4","key":"10.1016\/j.intimp.2025.115199_bb0050","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.bcp.2013.12.024","article-title":"Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers","volume":"88","author":"Reitz","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2025.115199_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134285","article-title":"The role of APOE in transgenic mouse models of AD","volume":"707","author":"Balu","year":"2019","journal-title":"Neurosci. Lett."},{"issue":"5123","key":"10.1016\/j.intimp.2025.115199_bb0060","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.intimp.2025.115199_bb0065","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1002\/alz.12991","article-title":"Effects of risk factors on longitudinal changes in brain structure and function in the progression of AD","volume":"19","author":"Verovnik","year":"2023","journal-title":"Alzheimers Dement."},{"issue":"8","key":"10.1016\/j.intimp.2025.115199_bb0070","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/ddr.22111","article-title":"Tryptamine: A privileged scaffold for the management of Alzheimer's disease","volume":"84","author":"Singh","year":"2023","journal-title":"Drug Dev. Res."},{"issue":"2","key":"10.1016\/j.intimp.2025.115199_bb0075","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.14478","article-title":"A recent update on huprine and its hybrids as a potential multifunctional agent for the treatment of Alzheimer's disease","volume":"103","author":"Singh","year":"2024","journal-title":"Chem. Biol. Drug Des."},{"issue":"5580","key":"10.1016\/j.intimp.2025.115199_bb0080","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.intimp.2025.115199_bb0085","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/nn.4018","article-title":"Three dimensions of the amyloid hypothesis: time, space and \u2018wingmen\u2019","volume":"18","author":"Musiek","year":"2015","journal-title":"Nat. Neurosci."},{"issue":"3","key":"10.1016\/j.intimp.2025.115199_bb0090","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/joim.12178","article-title":"Advances in the prevention of Alzheimer\u2019s disease and dementia","volume":"275","author":"Solomon","year":"2014","journal-title":"J. Intern. Med."},{"issue":"338","key":"10.1016\/j.intimp.2025.115199_bb0095","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf2362","article-title":"Ances, tau and Abeta imaging, CSF measures, and cognition in Alzheimer's disease","volume":"8","author":"Brier","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"7","key":"10.1016\/j.intimp.2025.115199_bb0100","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14856","article-title":"The neuroinflammatory role of microglia in Alzheimer's disease and their associated therapeutic targets","volume":"30","author":"AmeliMojarad","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"7","key":"10.1016\/j.intimp.2025.115199_bb0105","doi-asserted-by":"crossref","first-page":"908","DOI":"10.2174\/1570159X18666201111104509","article-title":"Glia-driven Neuroinflammation and systemic inflammation in Alzheimer's disease","volume":"19","author":"Hashioka","year":"2021","journal-title":"Curr. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115199_bb0110","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3233\/JAD-180004","article-title":"The vascular hypothesis of Alzheimer's disease: A key to preclinical prediction of dementia using neuroimaging","volume":"63","author":"de la Torre","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.intimp.2025.115199_bb0115","first-page":"43","article-title":"Alzheimer's disease puzzle: delving into pathogenesis hypotheses","volume":"15","author":"Nasb","year":"2024","journal-title":"Aging Dis."},{"issue":"1","key":"10.1016\/j.intimp.2025.115199_bb0120","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12974-016-0522-x","article-title":"The blockage of the Nogo\/NgR signal pathway in microglia alleviates the formation of Abeta plaques and tau phosphorylation in APP\/PS1 transgenic mice","volume":"13","author":"Fang","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.intimp.2025.115199_bb0125","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1474-4422(13)70276-X","article-title":"Targeting the \u03b2 secretase BACE1 for Alzheimer\u2019s disease therapy","volume":"13","author":"Yan","year":"2014","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115199_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/bc.bc_20_21","article-title":"Mini review: prospective therapeutic targets of Alzheimer's disease","volume":"8","author":"Mangal","year":"2022","journal-title":"Brain Circ."},{"issue":"4","key":"10.1016\/j.intimp.2025.115199_bb0135","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.neuron.2014.01.045","article-title":"ApoE and a\u03b2 in Alzheimer\u2019s disease: accidental encounters or partners?","volume":"81","author":"Kanekiyo","year":"2014","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.intimp.2025.115199_bb0140","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nm0796-783","article-title":"Alzheimer\u2019s disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules","volume":"2","author":"Alonso","year":"1996","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.intimp.2025.115199_bb0145","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1073\/pnas.91.12.5562","article-title":"Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease","volume":"91","author":"Alonso","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.intimp.2025.115199_bb0150","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1073\/pnas.94.1.298","article-title":"Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau","volume":"94","author":"Alonso","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.intimp.2025.115199_bb0155","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuron.2014.11.018","article-title":"NFkappaB-activated astroglial release of complement C3 compromises neuronal morphology and function associated with Alzheimer's disease","volume":"85","author":"Lian","year":"2015","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.intimp.2025.115199_bb0160","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1038\/s41467-021-26851-2","article-title":"Tau activates microglia via the PQBP1-cGAS-STING pathway to promote brain inflammation","volume":"12","author":"Jin","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2025.115199_bb0165","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40035-024-00445-6","article-title":"TRPV1 alleviates APOE4-dependent microglial antigen presentation and T cell infiltration in Alzheimer's disease","volume":"13","author":"Lu","year":"2024","journal-title":"Transl Neurodegener."},{"issue":"12","key":"10.1016\/j.intimp.2025.115199_bb0170","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13511","article-title":"Insights into T-cell dysfunction in Alzheimer's disease","volume":"20","author":"Dai","year":"2021","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.intimp.2025.115199_bb0175","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12979-024-00445-0","article-title":"Neuroinflammation in Alzheimer's disease: insights from peripheral immune cells","volume":"21","author":"Zhang","year":"2024","journal-title":"Immun. Ageing"},{"issue":"7399","key":"10.1016\/j.intimp.2025.115199_bb0180","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature11087","article-title":"Apolipoprotein E controls cerebrovascular integrity via cyclophilin A","volume":"485","author":"Bell","year":"2012","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.intimp.2025.115199_bb0185","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1093\/hmg\/ddx155","article-title":"APOE \u03b54\/\u03b54 diminishes neurotrophic function of human iPSC-derived astrocytes","volume":"26","author":"Zhao","year":"2017","journal-title":"Hum. Mol. Genet."},{"issue":"19","key":"10.1016\/j.intimp.2025.115199_bb0190","doi-asserted-by":"crossref","first-page":"E1807","DOI":"10.1073\/pnas.1220484110","article-title":"ApoE influences amyloid-\u03b2 (a\u03b2) clearance despite minimal apoE\/a\u03b2 association in physiological conditions","volume":"110","author":"Verghese","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2025.115199_bb0195","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nbd.2014.08.025","article-title":"Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases","volume":"72 Pt A","author":"Huang","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.intimp.2025.115199_bb0200","first-page":"5086250","article-title":"Molecular insight into the therapeutic promise of targeting APOE4 for Alzheimer's disease","author":"Mamun","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"6","key":"10.1016\/j.intimp.2025.115199_bb0205","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/glia.23974","article-title":"Expression and secretion of apoE isoforms in astrocytes and microglia during inflammation","volume":"69","author":"Lanfranco","year":"2021","journal-title":"Glia"},{"key":"10.1016\/j.intimp.2025.115199_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2022.101594","article-title":"APOE mediated neuroinflammation and neurodegeneration in Alzheimer's disease","volume":"59","author":"Parhizkar","year":"2022","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.intimp.2025.115199_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102471","article-title":"Emerging microglial biology highlights potential therapeutic targets for Alzheimer's disease","volume":"101","author":"Fan","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"6","key":"10.1016\/j.intimp.2025.115199_bb0220","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.neuron.2018.05.008","article-title":"APOE4 causes widespread molecular and cellular alterations associated with Alzheimer's disease phenotypes in human iPSC-derived brain cell types","volume":"98","author":"Lin","year":"2018","journal-title":"Neuron"},{"issue":"12","key":"10.1016\/j.intimp.2025.115199_bb0225","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41577-018-0051-1","article-title":"Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight","volume":"18","author":"Shi","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"19","key":"10.1016\/j.intimp.2025.115199_bb0230","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1523\/JNEUROSCI.5476-05.2006","article-title":"Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus","volume":"26","author":"Xu","year":"2006","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.intimp.2025.115199_bb0235","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tibs.2006.06.008","article-title":"Apolipoprotein E structure: insights into function","volume":"31","author":"Hatters","year":"2006","journal-title":"Trends Biochem. Sci."},{"issue":"10","key":"10.1016\/j.intimp.2025.115199_bb0240","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1074\/jbc.R800009200","article-title":"Understanding the association of apolipoprotein E4 with Alzheimer disease: clues from its structure","volume":"284","author":"Zhong","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.intimp.2025.115199_bb0245","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1038\/s41591-019-0611-3","article-title":"Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report","volume":"25","author":"Arboleda-Velasquez","year":"2019","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.intimp.2025.115199_bb0250","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00401-022-02467-8","article-title":"Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer's dementia","volume":"144","author":"Sepulveda-Falla","year":"2022","journal-title":"Acta Neuropathol."},{"issue":"613","key":"10.1016\/j.intimp.2025.115199_bb0255","doi-asserted-by":"crossref","first-page":"eabc9375","DOI":"10.1126\/scitranslmed.abc9375","article-title":"APOE3-Jacksonville (V236E) variant reduces self-aggregation and risk of dementia","volume":"13","author":"Liu","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.intimp.2025.115199_bb0260","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1750-1326-9-11","article-title":"ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer's disease","volume":"9","author":"Medway","year":"2014","journal-title":"Mol. Neurodegener."},{"issue":"7","key":"10.1016\/j.intimp.2025.115199_bb0265","first-page":"652","article-title":"Association of Rare APOE missense variants V236E and R251G with risk of Alzheimer disease, JAMA Neurol","volume":"79","author":"Le Guen","year":"2022"},{"issue":"8","key":"10.1016\/j.intimp.2025.115199_bb0270","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tibs.2006.06.008","article-title":"Apolipoprotein E structure: insights into function","volume":"31","author":"Hatters","year":"2006","journal-title":"Trends Biochem. Sci."},{"issue":"10","key":"10.1016\/j.intimp.2025.115199_bb0275","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1074\/jbc.R800009200","article-title":"Understanding the association of apolipoprotein E4 with Alzheimer disease: clues from its structure","volume":"284","author":"Zhong","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.intimp.2025.115199_bb0280","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13024-025-00843-y","article-title":"Apolipoprotein E in Alzheimer's disease: molecular insights and therapeutic opportunities","volume":"20","author":"Belaidi","year":"2025","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.intimp.2025.115199_bb0285","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00401-011-0892-1","article-title":"Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer's disease and apoE TR mouse cortex","volume":"123","author":"Arold","year":"2012","journal-title":"Acta Neuropathol."},{"issue":"7","key":"10.1016\/j.intimp.2025.115199_bb0290","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1194\/jlr.R075796","article-title":"Role of LRP1 in the pathogenesis of Alzheimer's disease: evidence from clinical and preclinical studies","volume":"58","author":"Shinohara","year":"2017","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.intimp.2025.115199_bb0295","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fnagi.2014.00093","article-title":"The low-density lipoprotein receptor-related protein 1 and amyloid-\u03b2 clearance in Alzheimer's disease","volume":"6","author":"Kanekiyo","year":"2014","journal-title":"Front. Aging Neurosci."},{"issue":"4","key":"10.1016\/j.intimp.2025.115199_bb0300","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.neuron.2014.08.005","article-title":"More than cholesterol transporters: lipoprotein receptors in CNS function and neurodegeneration","volume":"83","author":"Lane-Donovan","year":"2014","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.intimp.2025.115199_bb0305","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nrn2620","article-title":"Apolipoprotein E and its receptors in Alzheimer\u2019s disease: pathways, pathogenesis and therapy","volume":"10","author":"Bu","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.intimp.2025.115199_bb0310","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.biopsych.2017.03.003","article-title":"Apolipoprotein E, receptors, and modulation of Alzheimer's disease","volume":"83","author":"Zhao","year":"2018","journal-title":"Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.intimp.2025.115199_bb0315","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1172\/JCI36663","article-title":"apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain","volume":"118","author":"Deane","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.intimp.2025.115199_bb0320","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.apsb.2021.10.002","article-title":"Apolipoprotein E and Alzheimer's disease","volume":"12","author":"Troutwine","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.intimp.2025.115199_bb0325","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev.genom.1.1.507","article-title":"Apolipoprotein E: far more than a lipid transport protein","volume":"1","author":"Mahley","year":"2000","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"issue":"2","key":"10.1016\/j.intimp.2025.115199_bb0330","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/BF03325217","article-title":"A randomized controlled study on effects of ibuprofen on cognitive progression of Alzheimer\u2019s disease","volume":"21","author":"Pasqualetti","year":"2009","journal-title":"Aging Clin. Exp. Res."},{"issue":"2","key":"10.1016\/j.intimp.2025.115199_bb0335","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2174\/187152710791011991","article-title":"Mechanisms of action of non-steroidal anti-inflammatory drugs for the prevention of Alzheimer\u2019s disease","volume":"9","author":"Cole","year":"2010","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"6","key":"10.1016\/j.intimp.2025.115199_bb0340","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/alz.13020","article-title":"APOE and immunity: research highlights","volume":"19","author":"Kloske","year":"2023","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.intimp.2025.115199_bb0345","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13024-025-00825-0","article-title":"Decoding microglial immunometabolism: a new frontier in Alzheimer's disease research","volume":"20","author":"Jung","year":"2025","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.intimp.2025.115199_bb0350","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13024-022-00566-4","article-title":"APOE in the Bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases","volume":"17","author":"Fernandez-Calle","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.intimp.2025.115199_bb0355","doi-asserted-by":"crossref","first-page":"1554398","DOI":"10.3389\/fnagi.2025.1554398","article-title":"The dual role of microglia in Alzheimer's disease: from immune regulation to pathological progression","volume":"17","author":"He","year":"2025","journal-title":"Front. Aging Neurosci."},{"issue":"2","key":"10.1016\/j.intimp.2025.115199_bb0360","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.201709069","article-title":"Microglia in Alzheimer's disease","volume":"217","author":"Hansen","year":"2018","journal-title":"J. Cell Biol."},{"issue":"Pt B","key":"10.1016\/j.intimp.2025.115199_bb0365","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.bbr.2016.05.021","article-title":"Astrocytic face of Alzheimer's disease","volume":"322","author":"Zorec","year":"2017","journal-title":"Behav. Brain Res."},{"issue":"6","key":"10.1016\/j.intimp.2025.115199_bb0370","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms underlying inflammation in neurodegeneration","volume":"140","author":"Glass","year":"2010","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.intimp.2025.115199_bb0375","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.immuni.2017.06.006","article-title":"Reactive astrocytes: production, function, and therapeutic potential","volume":"46","author":"Liddelow","year":"2017","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.intimp.2025.115199_bb0380","doi-asserted-by":"crossref","DOI":"10.3390\/cells14040243","article-title":"From genetics to Neuroinflammation: the impact of ApoE4 on microglial function in Alzheimer's disease","volume":"14","author":"Dias","year":"2025","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.intimp.2025.115199_bb0385","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.stem.2024.10.005","article-title":"Microglia depletion reduces human neuronal APOE4-related pathologies in a chimeric Alzheimer's disease model","volume":"32","author":"Rao","year":"2025","journal-title":"Cell Stem Cell"},{"issue":"9","key":"10.1016\/j.intimp.2025.115199_bb0390","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/pcn.13704","article-title":"Synergism of ApoE4 and systemic infectious burden is mediated by the APOE-NLRP3 axis in Alzheimer's disease","volume":"78","author":"Liu","year":"2024","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.intimp.2025.115199_bb0395","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.immuni.2023.12.001","article-title":"Tavazoie, an exhausted-like microglial population accumulates in aged and APOE4 genotype Alzheimer's brains","volume":"57","author":"Millet","year":"2024","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.intimp.2025.115199_bb0400","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3390\/cimb43010018","article-title":"Isoform-specific effects of apolipoprotein E on markers of inflammation and toxicity in brain glia and neuronal cells in vitro","volume":"43","author":"Iannucci","year":"2021","journal-title":"Curr. Issues Mol. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115199_bb0405","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12974-022-02565-0","article-title":"Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer's disease","volume":"19","author":"Singh","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.intimp.2025.115199_bb0410","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.neuron.2017.03.042","article-title":"iPSC-Derived Human Microglia-like Cells to Study Neurological Diseases","volume":"94","author":"Abud","year":"2017","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.intimp.2025.115199_bb0415","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ng.801","article-title":"Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease","volume":"43","author":"Naj","year":"2011","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.intimp.2025.115199_bb0420","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","article-title":"TREM2 variants in Alzheimer\u2019s disease","volume":"368","author":"Guerreiro","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115199_bb0425","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1038\/s41467-023-37437-5","article-title":"Single-nucleus RNA-sequencing of autosomal dominant Alzheimer disease and risk variant carriers","volume":"14","author":"Brase","year":"2023","journal-title":"Nat. Commun."},{"issue":"23","key":"10.1016\/j.intimp.2025.115199_bb0430","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1016\/j.neuron.2024.09.006","article-title":"Alzheimer's disease-linked risk alleles elevate microglial cGAS-associated senescence and neurodegeneration in a tauopathy model","volume":"112","author":"Carling","year":"2024","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.intimp.2025.115199_bb0435","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/NEN.0b013e3182933788","article-title":"Differential relationships of reactive astrocytes and microglia to fibrillar amyloid deposits in Alzheimer disease","volume":"72","author":"Serrano-Pozo","year":"2013","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115199_bb0440","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/BF00687883","article-title":"Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain, An immunohistochemical study using a novel monoclonal antibody","volume":"77","author":"Haga","year":"1989","journal-title":"Acta Neuropathol."},{"issue":"10","key":"10.1016\/j.intimp.2025.115199_bb0445","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.1073\/pnas.94.10.5296","article-title":"Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease","volume":"94","author":"Du Yan","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.intimp.2025.115199_bb0450","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1523\/JNEUROSCI.23-07-02665.2003","article-title":"A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation","volume":"23","author":"Bamberger","year":"2003","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.intimp.2025.115199_bb0455","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ni.1836","article-title":"CD36 ligands promote sterile inflammation through assembly of a toll-like receptor 4 and 6 heterodimer","volume":"11","author":"Stewart","year":"2010","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115199_bb0460","first-page":"203","article-title":"The LPS receptor (CD14) links innate immunity with Alzheimer\u2019s disease, FASEB journal\u202f: official publication of the Federation of American Societies for","volume":"18","author":"Fassbender","year":"2004","journal-title":"Exp. Biol."},{"issue":"12","key":"10.1016\/j.intimp.2025.115199_bb0465","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1084\/jem.20021546","article-title":"CD36 mediates the innate host response to beta-amyloid","volume":"197","author":"El Khoury","year":"2003","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.intimp.2025.115199_bb0470","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3233\/JAD-160912","article-title":"Tau oligomers associate with inflammation in the brain and retina of Tauopathy mice and in neurodegenerative diseases","volume":"55","author":"Nilson","year":"2017","journal-title":"Journal of Alzheimer's disease : JAD."},{"issue":"3","key":"10.1016\/j.intimp.2025.115199_bb0475","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","article-title":"Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model","volume":"53","author":"Yoshiyama","year":"2007","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.intimp.2025.115199_bb0480","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/S0002-9440(10)63421-9","article-title":"Induction of inflammatory mediators and microglial activation in mice transgenic for mutant human P301S tau protein","volume":"165","author":"Bellucci","year":"2004","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115199_bb0485","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.3233\/JAD-170509","article-title":"In vivo visualization of tau accumulation, microglial activation, and brain atrophy in a mouse model of Tauopathy rTg4510","volume":"61","author":"Ishikawa","year":"2018","journal-title":"Journal of Alzheimer's disease : JAD."},{"key":"10.1016\/j.intimp.2025.115199_bb0490","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1742-2094-11-111","article-title":"Human APOE4 increases microglia reactivity at Abeta plaques in a mouse model of Abeta deposition","volume":"11","author":"Rodriguez","year":"2014","journal-title":"J. Neuroinflammation"},{"issue":"8036","key":"10.1016\/j.intimp.2025.115199_bb0495","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.1038\/s41586-024-08200-7","article-title":"Author correction: microglia-mediated T cell infiltration drives neurodegeneration in tauopathy","volume":"634","author":"Chen","year":"2024","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.intimp.2025.115199_bb0500","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","article-title":"A meta-analysis of cytokines in Alzheimer\u2019s disease","volume":"68","author":"Swardfager","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.intimp.2025.115199_bb0505","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/jnnp-2017-316201","article-title":"Peripheral inflammatory markers in Alzheimer's disease: a systematic review and meta-analysis of 175 studies","volume":"88","author":"Lai","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"10","key":"10.1016\/j.intimp.2025.115199_bb0510","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1212\/WNL.0b013e3181b6bb95","article-title":"Systemic inflammation and disease progression in Alzheimer disease","volume":"73","author":"Holmes","year":"2009","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.intimp.2025.115199_bb0515","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3233\/JAD-2010-1252","article-title":"Vitamin B12 levels in Alzheimer\u2019s disease: association with clinical features and cytokine production","volume":"19","author":"Politis","year":"2010","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.intimp.2025.115199_bb0520","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1212\/WNL.0b013e318225ae07","article-title":"Proinflammatory cytokines, sickness behavior, and Alzheimer disease","volume":"77","author":"Holmes","year":"2011","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.intimp.2025.115199_bb0525","first-page":"433","article-title":"Association between cytokine production and disease severity in Alzheimer\u2019s disease","volume":"13","author":"Jabbari Azad","year":"2014","journal-title":"Iran. J. Allergy Asthma Immunol."},{"issue":"7790","key":"10.1016\/j.intimp.2025.115199_bb0530","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41586-019-1895-7","article-title":"Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer's disease","volume":"577","author":"Gate","year":"2020","journal-title":"Nature"},{"issue":"7953","key":"10.1016\/j.intimp.2025.115199_bb0535","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s41586-023-05788-0","article-title":"Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy","volume":"615","author":"Chen","year":"2023","journal-title":"Nature"},{"issue":"Suppl. 3","key":"10.1016\/j.intimp.2025.115199_bb0540","article-title":"APOE4 genetic burden and female sex impact immune profile in brain and periphery in aged mice","volume":"17","author":"M. A, S. M, D. N, R. KE, B. RD","year":"2021","journal-title":"Alzheimers Dement."},{"issue":"5","key":"10.1016\/j.intimp.2025.115199_bb0545","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/ars.2011.3895","article-title":"Amyloid Beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy","volume":"15","author":"Carrano","year":"2011","journal-title":"Antioxid. Redox Signal."},{"issue":"19","key":"10.1016\/j.intimp.2025.115199_bb0550","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1212\/WNL.0000000000000403","article-title":"Occludin deficiency with BACE1 elevation in cerebral amyloid angiopathy","volume":"82","author":"Cheng","year":"2014","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.intimp.2025.115199_bb0555","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neulet.2006.03.047","article-title":"Amyloid beta-peptide1-42 alters tight junction protein distribution and expression in brain microvessel endothelial cells","volume":"401","author":"Marco","year":"2006","journal-title":"Neurosci. Lett."},{"issue":"8","key":"10.1016\/j.intimp.2025.115199_bb0560","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/s41593-022-01127-0","article-title":"Peripheral apoE4 enhances Alzheimer's pathology and impairs cognition by compromising cerebrovascular function","volume":"25","author":"Liu","year":"2022","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.intimp.2025.115199_bb0565","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0006-8993(91)91092-F","article-title":"Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer\u2019s disease and kuru plaque amyloid in Creutzfeldt-Jakob disease","volume":"541","author":"Namba","year":"1991","journal-title":"Brain Res."},{"issue":"21","key":"10.1016\/j.intimp.2025.115199_bb0570","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1523\/JNEUROSCI.0887-09.2009","article-title":"Human APOE isoform-dependent effects on brain beta-amyloid levels in PDAPP transgenic mice","volume":"29","author":"Bales","year":"2009","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.intimp.2025.115199_bb0575","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/nbdi.2002.0483","article-title":"Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer\u2019s disease","volume":"9","author":"Fagan","year":"2002","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"10.1016\/j.intimp.2025.115199_bb0580","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1073\/pnas.050004797","article-title":"Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer\u2019s disease","volume":"97","author":"Holtzman","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2025.115199_bb0585","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","article-title":"Amyloid precursor protein processing and Alzheimer's disease","volume":"34","author":"O'Brien","year":"2011","journal-title":"Annu. Rev. Neurosci."},{"issue":"9","key":"10.1016\/j.intimp.2025.115199_bb0590","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","article-title":"Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies","volume":"15","author":"Yamazaki","year":"2019","journal-title":"Nat. Rev. Neurol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115199_bb0595","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.cell.2016.12.044","article-title":"ApoE2, ApoE3, and ApoE4 differentially stimulate APP transcription and a\u03b2 secretion","volume":"168","author":"Huang","year":"2017","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.intimp.2025.115199_bb0600","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/j.stemcr.2021.07.017","article-title":"APOE4-carrying human astrocytes oversupply cholesterol to promote neuronal lipid raft expansion and a\u03b2 generation","volume":"16","author":"Lee","year":"2021","journal-title":"Stem Cell Rep."},{"issue":"33","key":"10.1016\/j.intimp.2025.115199_bb0605","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2102191118","article-title":"Regulation of beta-amyloid production in neurons by astrocyte-derived cholesterol","volume":"118","author":"Wang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.intimp.2025.115199_bb0610","doi-asserted-by":"crossref","DOI":"10.1002\/bies.201700062","article-title":"Transcriptional regulation of APP by apoE: to boldly go where no isoform has gone before: ApoE, APP transcription and AD: hypothesised mechanisms and existing knowledge gaps","volume":"39","author":"Lee","year":"2017","journal-title":"Bioessays"},{"key":"10.1016\/j.intimp.2025.115199_bb0615","doi-asserted-by":"crossref","unstructured":"E.M. Castano, F. Prelli, T. Wisniewski, A. Golabek, R.A. Kumar, C. Soto, B. Frangione, Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E, Biochem. J. 306 (Pt 2) (1995) 599\u2013604.","DOI":"10.1042\/bj3060599"},{"issue":"5","key":"10.1016\/j.intimp.2025.115199_bb0620","first-page":"1030","article-title":"Acceleration of Alzheimer\u2019s fibril formation by apolipoprotein E in vitro","volume":"145","author":"Wisniewski","year":"1994","journal-title":"Am. J. Pathol."},{"issue":"6501","key":"10.1016\/j.intimp.2025.115199_bb0625","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/372092a0","article-title":"Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments","volume":"372","author":"Ma","year":"1994","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.intimp.2025.115199_bb0630","doi-asserted-by":"crossref","first-page":"7267","DOI":"10.1074\/jbc.AAC118.003576","article-title":"Role of apolipoprotein E in \u03b2-amyloidogenesis: isoform-specific effects on protofibril to fibril conversion of a\u03b2 in vitro and brain a\u03b2 deposition in vivo","volume":"293","author":"Hori","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.intimp.2025.115199_bb0635","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21124371","article-title":"ApoE4 astrocytes secrete basement membranes rich in fibronectin and poor in laminin compared to ApoE3 astrocytes","volume":"21","author":"Keable","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"43","key":"10.1016\/j.intimp.2025.115199_bb0640","doi-asserted-by":"crossref","first-page":"15181","DOI":"10.1523\/JNEUROSCI.1542-12.2012","article-title":"Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid \u03b2 peptide","volume":"32","author":"Hashimoto","year":"2012","journal-title":"J. Neurosci."},{"issue":"40","key":"10.1016\/j.intimp.2025.115199_bb0645","doi-asserted-by":"crossref","first-page":"6323","DOI":"10.1021\/bi5008172","article-title":"The binding of apolipoprotein E to oligomers and fibrils of amyloid-\u03b2 alters the kinetics of amyloid aggregation","volume":"53","author":"Garai","year":"2014","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.intimp.2025.115199_bb0650","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1007\/s12035-018-1237-z","article-title":"APOE and Alzheimer's disease: evidence mounts that targeting APOE4 may combat Alzheimer's pathogenesis","volume":"56","author":"Uddin","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115199_bb0655","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/ana.24270","article-title":"Amyloid-\u03b2 efflux from the central nervous system into the plasma","volume":"76","author":"Roberts","year":"2014","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.intimp.2025.115199_bb0660","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1084\/jem.20171406","article-title":"Alzheimer's disease: A matter of blood-brain barrier dysfunction?","volume":"214","author":"Montagne","year":"2017","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.intimp.2025.115199_bb0665","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.jcbfm.9600419","article-title":"Transport pathways for clearance of human Alzheimer\u2019s amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system","volume":"27","author":"Bell","year":"2007","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"7","key":"10.1016\/j.intimp.2025.115199_bb0670","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nm890","article-title":"RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain","volume":"9","author":"Deane","year":"2003","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115199_bb0675","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/jcbfm.2014.172","article-title":"Human apolipoprotein E \u025b4 expression impairs cerebral vascularization and blood-brain barrier function in mice","volume":"35","author":"Alata","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"1","key":"10.1016\/j.intimp.2025.115199_bb0680","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000337231","article-title":"A multifaceted role for apoE in the clearance of beta-amyloid across the blood-brain barrier","volume":"11","author":"Bachmeier","year":"2013","journal-title":"Neurodegener. Dis."},{"issue":"2","key":"10.1016\/j.intimp.2025.115199_bb0685","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/72237","article-title":"Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition","volume":"6","author":"Iwata","year":"2000","journal-title":"Nat. Med."},{"issue":"49","key":"10.1016\/j.intimp.2025.115199_bb0690","doi-asserted-by":"crossref","first-page":"32730","DOI":"10.1074\/jbc.273.49.32730","article-title":"Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation","volume":"273","author":"Qiu","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.intimp.2025.115199_bb0695","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/01.jnen.0000240463.87886.9a","article-title":"Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy","volume":"65","author":"Miners","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115199_bb0700","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0002-9440(10)63822-9","article-title":"Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer\u2019s disease is associated with the apolipoprotein E-epsilon4 allele","volume":"162","author":"Cook","year":"2003","journal-title":"Am. J. Pathol."},{"issue":"8","key":"10.1016\/j.intimp.2025.115199_bb0705","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","article-title":"Clearance systems in the brain-implications for Alzheimer disease","volume":"11","author":"Tarasoff-Conway","year":"2015","journal-title":"Nat. Rev. Neurol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115199_bb0710","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.neuron.2018.05.008","article-title":"APOE4 causes widespread molecular and cellular alterations associated with Alzheimer's disease phenotypes in human iPSC-derived brain cell types","volume":"98","author":"Lin","year":"2018","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.intimp.2025.115199_bb0715","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/ane.13551","article-title":"Microglia and immunotherapy in Alzheimer's disease","volume":"145","author":"Li","year":"2022","journal-title":"Acta Neurol. Scand."},{"issue":"4","key":"10.1016\/j.intimp.2025.115199_bb0720","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1523\/JNEUROSCI.21-04-01179.2001","article-title":"beta-amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis","volume":"21","author":"Combs","year":"2001","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.intimp.2025.115199_bb0725","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/0304-3940(91)90490-K","article-title":"Elevated circulating tumor necrosis factor levels in Alzheimer\u2019s disease","volume":"129","author":"Fillit","year":"1991","journal-title":"Neurosci. Lett."},{"issue":"9","key":"10.1016\/j.intimp.2025.115199_bb0730","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/jnnp.74.9.1200","article-title":"Intrathecal inflammation precedes development of Alzheimer\u2019s disease","volume":"74","author":"Tarkowski","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.intimp.2025.115199_bb0735","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.cell.2020.02.013","article-title":"Repopulating microglia promote brain repair in an IL-6-dependent manner","volume":"180","author":"Willis","year":"2020","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.intimp.2025.115199_bb0740","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.tins.2022.10.007","article-title":"Interferon gamma: a master cytokine in microglia-mediated neural network dysfunction and neurodegeneration","volume":"45","author":"Kann","year":"2022","journal-title":"Trends Neurosci."},{"issue":"12","key":"10.1016\/j.intimp.2025.115199_bb0745","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jamaneurol.2023.4038","article-title":"ApoE4 and connectivity-mediated spreading of tau pathology at lower amyloid levels","volume":"80","author":"Steward","year":"2023","journal-title":"JAMA Neurol."},{"issue":"4","key":"10.1016\/j.intimp.2025.115199_bb0750","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/jnc.12484","article-title":"Blocking the apolipoprotein E\/amyloid \u03b2 interaction in triple transgenic mice ameliorates Alzheimer\u2019s disease related amyloid \u03b2 and tau pathology","volume":"128","author":"Liu","year":"2014","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.intimp.2025.115199_bb0755","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1001\/jamaneurol.2019.4421","article-title":"Association of Apolipoprotein E epsilon4 with medial temporal tau independent of amyloid-beta","volume":"77","author":"Therriault","year":"2020","journal-title":"JAMA Neurol."},{"issue":"23","key":"10.1016\/j.intimp.2025.115199_bb0760","doi-asserted-by":"crossref","first-page":"11183","DOI":"10.1073\/pnas.91.23.11183","article-title":"Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease","volume":"91","author":"Strittmatter","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.intimp.2025.115199_bb0765","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1523\/JNEUROSCI.4315-03.2004","article-title":"Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice","volume":"24","author":"Brecht","year":"2004","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.intimp.2025.115199_bb0770","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/brain\/awae234","article-title":"Brain inflammation co-localizes highly with tau in mild cognitive impairment due to early-onset Alzheimer's disease","volume":"148","author":"Appleton","year":"2025","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.intimp.2025.115199_bb0775","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12974-023-02853-3","article-title":"Tau and neuroinflammation in Alzheimer's disease: interplay mechanisms and clinical translation","volume":"20","author":"Chen","year":"2023","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.intimp.2025.115199_bb0780","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13578-022-00828-0","article-title":"Lipid metabolism and storage in neuroglia: role in brain development and neurodegenerative diseases","volume":"12","author":"Yang","year":"2022","journal-title":"Cell Biosci."},{"key":"10.1016\/j.intimp.2025.115199_bb0785","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.647990","article-title":"Cholesterol, atherosclerosis, and APOE in vascular contributions to cognitive impairment and dementia (VCID): potential mechanisms and therapy","volume":"13","author":"Duong","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"13","key":"10.1016\/j.intimp.2025.115199_bb0790","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/j.cell.2022.05.017","article-title":"Cholesterol and matrisome pathways dysregulated in astrocytes and microglia","volume":"185","author":"Tcw","year":"2022","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.intimp.2025.115199_bb0795","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.neuron.2023.10.023","article-title":"Amelioration of tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist","volume":"112","author":"Litvinchuk","year":"2024","journal-title":"Neuron"},{"key":"10.1016\/j.intimp.2025.115199_bb0800","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1194\/jlr.R800080-JLR200","article-title":"Hannun, bioactive sphingolipids: metabolism and function","author":"Bartke","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.intimp.2025.115199_bb0805","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.addr.2019.12.003","article-title":"Sphingolipids in Alzheimer's disease, how can we target them?","volume":"159","author":"Crivelli","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.intimp.2025.115199_bb0810","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2051-5960-2-9","article-title":"Loss of the neuroprotective factor sphingosine 1-phosphate early in Alzheimer's disease pathogenesis","volume":"2","author":"Couttas","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.intimp.2025.115199_bb0815","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113240","article-title":"FTY720 decreases ceramides levels in the brain and prevents memory impairments in a mouse model of familial Alzheimer's disease expressing APOE4","volume":"152","author":"Crivelli","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"10 Pt A","key":"10.1016\/j.intimp.2025.115199_bb0820","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.bbalip.2017.07.004","article-title":"Carriers of an apolipoprotein E epsilon 4 allele are more vulnerable to a dietary deficiency in omega-3 fatty acids and cognitive decline","volume":"1862","author":"Nock","year":"2017","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"9","key":"10.1016\/j.intimp.2025.115199_bb0825","doi-asserted-by":"crossref","first-page":"7092","DOI":"10.1111\/ejn.15472","article-title":"Diet enriched in omega-3 fatty acids alleviates olfactory system deficits in APOE4 transgenic mice","volume":"54","author":"Lessard-Beaudoin","year":"2021","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.intimp.2025.115199_bb0830","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbas.2022.100046","article-title":"A diet rich in docosahexaenoic acid enhances reactive astrogliosis and ramified microglia morphology in apolipoprotein E epsilon 4-targeted replacement mice","volume":"2","author":"Chappus-McCendie","year":"2022","journal-title":"Aging Brain."},{"issue":"8006","key":"10.1016\/j.intimp.2025.115199_bb0835","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41586-024-07185-7","article-title":"APOE4\/4 is linked to damaging lipid droplets in Alzheimer's disease microglia","volume":"628","author":"Haney","year":"2024","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.intimp.2025.115199_bb0840","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.stem.2022.07.005","article-title":"Lipid accumulation induced by APOE4 impairs microglial surveillance of neuronal-network activity","volume":"29","author":"Victor","year":"2022","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.intimp.2025.115199_bb0845","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13024-022-00542-y","article-title":"TREM2 in the pathogenesis of AD: a lipid metabolism regulator and potential metabolic therapeutic target","volume":"17","author":"Li","year":"2022","journal-title":"Mol. Neurodegener."},{"issue":"5","key":"10.1016\/j.intimp.2025.115199_bb0850","article-title":"Metabolic disturbances of a high-fat diet are dependent on APOE","volume":"6","author":"Jones","year":"2019","journal-title":"Genotype and Sex, eNeuro."},{"key":"10.1016\/j.intimp.2025.115199_bb0855","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fendo.2013.00052","article-title":"Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies","volume":"4","author":"McArdle","year":"2013","journal-title":"Front Endocrinol (Lausanne)."},{"key":"10.1016\/j.intimp.2025.115199_bb0860","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3389\/fncel.2017.00216","article-title":"Brain and peripheral atypical inflammatory mediators potentiate Neuroinflammation and neurodegeneration","volume":"11","author":"Kempuraj","year":"2017","journal-title":"Front. Cell. Neurosci."},{"issue":"6","key":"10.1016\/j.intimp.2025.115199_bb0865","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s43587-021-00073-z","article-title":"APOE4 accelerates advanced-stage vascular and neurodegenerative disorder in old Alzheimer's mice via cyclophilin A independently of amyloid-\u03b2","volume":"1","author":"Montagne","year":"2021","journal-title":"Nat Aging."},{"issue":"2","key":"10.1016\/j.intimp.2025.115199_bb0870","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","article-title":"The blood-brain barrier in health and chronic neurodegenerative disorders","volume":"57","author":"Zlokovic","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.intimp.2025.115199_bb0875","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.neubiorev.2016.06.014","article-title":"Insights on the pathophysiology of Alzheimer's disease: the crosstalk between amyloid pathology, neuroinflammation and the peripheral immune system","volume":"68","author":"Ferreira","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.intimp.2025.115199_bb0880","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2016.07.007","article-title":"The blood-brain barrier in Alzheimer's disease","volume":"107","author":"Zenaro","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.intimp.2025.115199_bb0885","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3389\/fimmu.2020.00754","article-title":"The important Interface between apolipoprotein E and Neuroinflammation in Alzheimer's disease","volume":"11","author":"Kloske","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115199_bb0890","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.brainresrev.2005.07.004","article-title":"The critical component to establish in vitro BBB model: Pericyte","volume":"50","author":"L. CH,K. KH","year":"2005","journal-title":"Brain Res. Brain Res. Rev."},{"issue":"7323","key":"10.1016\/j.intimp.2025.115199_bb0895","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature09522","article-title":"Pericytes regulate the blood-brain barrier","volume":"468","author":"Armulik","year":"2010","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.intimp.2025.115199_bb0900","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/jcbfm.2015.44","article-title":"Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer\u2019s disease","volume":"36","author":"Halliday","year":"2016","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"5","key":"10.1016\/j.intimp.2025.115199_bb0905","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.cell.2015.10.067","article-title":"Establishment and dysfunction of the blood-brain barrier","volume":"163","author":"Zhao","year":"2015","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.intimp.2025.115199_bb0910","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1161\/ATVBAHA.118.312261","article-title":"Apolipoprotein E4 expression causes gain of toxic function in isogenic human induced pluripotent stem cell-derived endothelial cells","volume":"39","author":"Rieker","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.intimp.2025.115199_bb0915","article-title":"APOE- \u03b54-induced Fibronectin at the blood-brain barrier is a conserved pathological mediator of disrupted astrocyte-endothelia interaction in Alzheimer's disease","author":"Bhattarai","year":"2025","journal-title":"bioRxiv"},{"issue":"7","key":"10.1016\/j.intimp.2025.115199_bb0920","doi-asserted-by":"crossref","first-page":"7110","DOI":"10.1021\/acsnano.7b02755","article-title":"Detection of an integrin-binding Mechanoswitch within fibronectin during tissue formation and fibrosis","volume":"11","author":"Cao","year":"2017","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.intimp.2025.115199_bb0925","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s00401-024-02721-1","article-title":"Rare genetic variation in fibronectin 1 (FN1) protects against APOEepsilon4 in Alzheimer's disease","volume":"147","author":"Bhattarai","year":"2024","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.intimp.2025.115199_bb0930","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.neurobiolaging.2019.09.020","article-title":"Linking APOE-\u03b54, blood-brain barrier dysfunction, and inflammation to Alzheimer's pathology","volume":"85","author":"Riphagen","year":"2020","journal-title":"Neurobiol. Aging"},{"issue":"9","key":"10.1016\/j.intimp.2025.115199_bb0935","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.4049\/jimmunol.161.9.4992","article-title":"Role of IL-6 and the soluble IL-6 receptor in inhibition of VCAM-1 gene expression","volume":"161","author":"Oh","year":"1998","journal-title":"J. Immunol."},{"issue":"6 Pt A","key":"10.1016\/j.intimp.2025.115199_bb0940","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.bbamcr.2016.03.018","article-title":"The role of interleukin-6 signaling in nervous tissue","volume":"1863","author":"Rothaug","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"11","key":"10.1016\/j.intimp.2025.115199_bb0945","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13501","article-title":"Monomeric C-reactive protein via endothelial CD31 for neurovascular inflammation in an ApoE genotype-dependent pattern: A risk factor for Alzheimer's disease?","volume":"20","author":"Zhang","year":"2021","journal-title":"Aging Cell"},{"key":"10.1016\/j.intimp.2025.115199_bb0950","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.neurobiolaging.2022.03.011","article-title":"ApoE4 reduction: an emerging and promising therapeutic strategy for Alzheimer's disease","volume":"115","author":"Li","year":"2022","journal-title":"Neurobiol. Aging"},{"issue":"5","key":"10.1016\/j.intimp.2025.115199_bb0955","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.neuron.2017.11.014","article-title":"Age-dependent effects of apoE reduction using antisense oligonucleotides in a model of \u03b2-amyloidosis","volume":"96","author":"Huynh","year":"2017","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.intimp.2025.115199_bb0960","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1002\/alz.13703","article-title":"Silencing Apoe with divalent-siRNAs improves amyloid burden and activates immune response pathways in Alzheimer's disease","volume":"20","author":"Ferguson","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.intimp.2025.115199_bb0965","doi-asserted-by":"crossref","DOI":"10.1177\/20406223221081605","article-title":"Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer's disease?","volume":"13","author":"Vecchio","year":"2022","journal-title":"Ther. Adv. Chronic Dis."},{"issue":"52","key":"10.1016\/j.intimp.2025.115199_bb0970","doi-asserted-by":"crossref","first-page":"43236","DOI":"10.1074\/jbc.M508780200","article-title":"Deletion of Abca1 increases Abeta deposition in the PDAPP transgenic mouse model of Alzheimer disease","volume":"280","author":"Wahrle","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.intimp.2025.115199_bb0975","first-page":"671","article-title":"Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease","volume":"118","author":"Wahrle","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.intimp.2025.115199_bb0980","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3233\/JAD-160467","article-title":"ABCA1 agonist reverses the ApoE4-driven cognitive and brain pathologies","volume":"54","author":"Boehm-Cagan","year":"2016","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.intimp.2025.115199_bb0985","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJMcibr1906886","article-title":"Controlling CRISPR-Cas9 gene editing","volume":"381","author":"Dowdy","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.intimp.2025.115199_bb0990","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","article-title":"The role of apolipoprotein E in Alzheimer's disease","volume":"63","author":"Kim","year":"2009","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.intimp.2025.115199_bb0995","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat. Rev. Neurol."},{"issue":"7673","key":"10.1016\/j.intimp.2025.115199_bb1000","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature24016","article-title":"ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy","volume":"549","author":"Shi","year":"2017","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.intimp.2025.115199_bb1005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22031244","article-title":"APOE: the new frontier in the development of a therapeutic target towards precision medicine in late-onset Alzheimer's","volume":"22","author":"Yang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"19","key":"10.1016\/j.intimp.2025.115199_bb1010","doi-asserted-by":"crossref","first-page":"17217","DOI":"10.1074\/jbc.M110.217380","article-title":"Structure-dependent impairment of intracellular apolipoprotein E4 trafficking and its detrimental effects are rescued by small-molecule structure correctors","volume":"286","author":"Brodbeck","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"21","key":"10.1016\/j.intimp.2025.115199_bb1015","doi-asserted-by":"crossref","first-page":"8997","DOI":"10.1021\/jm3008618","article-title":"Small-molecule structure correctors target abnormal protein structure and function: structure corrector rescue of apolipoprotein E4-associated neuropathology","volume":"55","author":"Mahley","year":"2012","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.intimp.2025.115199_bb1020","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1074\/jbc.M110.151084","article-title":"Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease","volume":"286","author":"Chen","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.intimp.2025.115199_bb1025","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.1074\/jbc.M111.276162","article-title":"Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons","volume":"287","author":"Chen","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.intimp.2025.115199_bb1030","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","article-title":"Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector","volume":"24","author":"Wang","year":"2018","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.intimp.2025.115199_bb1035","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0002-9440(10)63355-X","article-title":"A synthetic peptide blocking the apolipoprotein E\/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice","volume":"165","author":"Sadowski","year":"2004","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115199_bb1040","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.ajpath.2013.01.034","article-title":"Blocking the interaction between apolipoprotein E and a\u03b2 reduces intraneuronal accumulation of a\u03b2 and inhibits synaptic degeneration","volume":"182","author":"Kuszczyk","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"49","key":"10.1016\/j.intimp.2025.115199_bb1045","doi-asserted-by":"crossref","first-page":"18787","DOI":"10.1073\/pnas.0604011103","article-title":"Blocking the apolipoprotein E\/amyloid-beta interaction as a potential therapeutic approach for Alzheimer\u2019s disease","volume":"103","author":"Sadowski","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.intimp.2025.115199_bb1050","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.npep.2010.03.001","article-title":"Abeta20-29 peptide blocking apoE\/Abeta interaction reduces full-length Abeta42\/40 fibril formation and cytotoxicity in vitro","volume":"44","author":"Hao","year":"2010","journal-title":"Neuropeptides"},{"key":"10.1016\/j.intimp.2025.115199_bb1055","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.630502","article-title":"APOE and Alzheimer's disease: from lipid transport to physiopathology and therapeutics","volume":"15","author":"Husain","year":"2021","journal-title":"Front. Neurosci."},{"issue":"212","key":"10.1016\/j.intimp.2025.115199_bb1060","doi-asserted-by":"crossref","first-page":"212ra161","DOI":"10.1126\/scitranslmed.3007000","article-title":"Gene transfer of human Apoe isoforms results in differential modulation of amyloid deposition and neurotoxicity in mouse brain","volume":"5","author":"Hudry","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.intimp.2025.115199_bb1065","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13024-015-0001-3","article-title":"Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Abeta metabolism in apoE4-targeted replacement mice","volume":"10","author":"Hu","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.intimp.2025.115199_bb1070","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neuroscience.2023.11.023","article-title":"ApoE mimic peptide COG1410 reduces a\u03b2 deposition and improves cognitive function by inducing the transformation of A1\/A2 reactive astrocytes and increasing the BDNF concentration in brain of APP\/PS1 double transgenic mice","volume":"537","author":"Qiao","year":"2024","journal-title":"Neuroscience"},{"issue":"1\u20134","key":"10.1016\/j.intimp.2025.115199_bb1075","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000334914","article-title":"APOE-mimetic peptides reduce behavioral deficits, plaques and tangles in Alzheimer\u2019s disease transgenics","volume":"10","author":"Vitek","year":"2012","journal-title":"Neurodegener. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2025.115199_bb1080","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000341299","article-title":"The apolipoprotein-E-mimetic COG112 protects amyloid precursor protein intracellular domain-overexpressing animals from Alzheimer\u2019s disease-like pathological features","volume":"12","author":"Ghosal","year":"2013","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.intimp.2025.115199_bb1085","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.146685","article-title":"ApoE mimetic improves pathology and memory in a model of Alzheimer's disease","volume":"1733","author":"Krishnamurthy","year":"2020","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.intimp.2025.115199_bb1090","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2174\/187152710791011991","article-title":"Mechanisms of action of non-steroidal anti-inflammatory drugs for the prevention of Alzheimer\u2019s disease","volume":"9","author":"Cole","year":"2010","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"2","key":"10.1016\/j.intimp.2025.115199_bb1095","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/aps.2009.205","article-title":"Immunomodulatory activity of andrographolide on macrophage activation and specific antibody response","volume":"31","author":"Wang","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2025.115199_bb1100","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bcp.2017.03.024","article-title":"Is there a future for andrographolide to be an anti-inflammatory drug? Deciphering its major mechanisms of action","volume":"139","author":"Tan","year":"2017","journal-title":"Biochem. Pharmacol."},{"issue":"10","key":"10.1016\/j.intimp.2025.115199_bb1105","doi-asserted-by":"crossref","first-page":"7950","DOI":"10.1007\/s12035-024-04088-6","article-title":"Andrographolide improves ApoE4-mediated blood-brain barrier injury by alleviating inflammation","volume":"61","author":"Zhou","year":"2024","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115199_bb1110","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3233\/JAD-2000-2105","article-title":"Lower counts of Astroglia and activated microglia in patients with Alzheimer's disease with regular use of non-steroidal anti-inflammatory drugs","volume":"2","author":"Alafuzoff","year":"2000","journal-title":"J. Alzheimers Dis."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925011890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925011890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T05:05:33Z","timestamp":1757912733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925011890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":222,"alternative-id":["S1567576925011890"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115199","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unraveling APOE4: The dual role in CNS and peripheral inflammation in Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115199","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115199"}}